On this page · 5 sections

Hypaque Meglumine (Intravenous)

Generic name: diatrizoate

Brand names: Cystografin, Cystografin-Dilute, Hypaque-Cysto, Hypaque Meglumine, Reno-30, Reno-60, Reno-Dip

Last updated May 28, 2026 0 views
Share

Uses for Hypaque Meglumine

Diatrizoate meglumine injection is used to help diagnose or find problems in the urinary bladder. It is a radiopaque contrast agent. Contrast agents are used to create a clear picture of different parts of the body during certain medical procedures, like retrograde cystourethrography.

This medicine is to be used only by or under the direct supervision of a doctor.

This section was rewritten for readability and reviewed for meaning.

Precautions while using Hypaque Meglumine

Your doctor will monitor your progress closely while you are getting this medicine. This will help your doctor determine if the medicine is working correctly and if you should keep receiving it.

Severe reactions may happen while you are receiving this medicine. Inform your doctor if you experience seizures, difficulty breathing, or chest tightness after receiving this medicine.

Before undergoing any medical tests, inform the medical doctor in charge that you are receiving this medicine. The results of some tests may be influenced by this medicine.

This section was rewritten for readability and reviewed for meaning.

Before using Hypaque Meglumine

In deciding to use a medicine, you and your doctor need to weigh the risks against the benefits. Here are some important considerations for this medicine:

Allergies

Let your doctor know if you have ever had any unusual or allergic reactions to this medicine or any other medicines. Also inform your healthcare professional about any other allergies you may have, such as to foods, dyes, preservatives, or animals. For non-prescription products, carefully read the label or package ingredients.

Pediatric

There is no information about how diatrizoate meglumine injection affects children. Its safety and effectiveness have not been established for this age group.

Geriatric

There is no information about how diatrizoate meglumine injection affects older adults.

Breast Feeding

Studies suggest that this medication poses minimal risk to the infant when used during breastfeeding.

Interactions with Medicines

Some medicines should never be used together, while others may be used together even if an interaction could occur. If you are receiving this medicine, it is very important for your healthcare professional to know if you are taking any of the medicines listed below. The following interactions are significant but may not include all possible interactions.

Using this medicine with any of the following medicines is usually not recommended, but may be necessary in some cases. If both medicines are prescribed, your doctor may adjust the dose or frequency of use for one or both medicines.

  • Propranolol

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be taken at the same time as food or specific types of food due to possible interactions. Using alcohol or tobacco with certain medicines may also cause interactions. Talk to your healthcare professional about using your medicine with food, alcohol, or tobacco.

Other Medical Problems

Other medical issues may affect the use of this medicine. Make sure to inform your doctor if you have any other medical problems, especially:

  • Allergy to iodine or other contrast agents, or a history of
  • Asthma, or a history of—Use with caution. This may increase the risk of more serious side effects.
  • Urinary tract infection—Use with caution. This may worsen this condition.

This section was rewritten for readability and reviewed for meaning.

Side Effects of Hypaque Meglumine

Along with its necessary effects, this medicine may cause some unwanted effects. Not all of these side effects may happen, but if they do, you may need medical help.

Check with your doctor or nurse right away if any of the following side effects occur:

Incidence not known

  • Blood in the urine
  • convulsions
  • cough
  • decrease in the amount of urine
  • difficulty with swallowing
  • dizziness
  • fast heartbeat
  • hives, itching, or rash
  • not able to pass urine
  • pain or burning while urinating
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • shortness of breath
  • tightness in the chest
  • unusual tiredness or weakness

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

In the U.S.

  • Cystografin
  • Cystografin-Dilute
  • Hypaque-Cysto
  • Hypaque Meglumine
  • Reno-30
  • Reno-60
  • Reno-Dip

Available Dosage Forms:

  • Solution

Therapeutic Class: Radiological Ionic Contrast Media

This section was rewritten for readability and reviewed for meaning.

Proper use of Hypaque Meglumine

A doctor or other trained health professional will give you this medicine in a hospital. This medicine is given through a needle placed in one of your veins.

Your doctor may give you a laxative the night before the test, and may recommend a low residue diet the day before the procedure.

Related medicines

Before you take this medicine: the information on this page is general and may not cover your personal circumstances. Read the label supplied with your medicine and ask a pharmacist or doctor if you are unsure, especially if you are pregnant, breastfeeding, taking other medicines or managing a long-term condition.
General medicine information Consumer-friendly language

Content is provided for education and is not medical advice. See our medical disclaimer.